Does Tandem Diabetes Care Inc. (TNDM) Have Insiders Selling Shares?


As of Friday close, Tandem Diabetes Care Inc.’s (NASDAQ:TNDM) stock was down -$0.28, moving down -0.68 percent to $41.14. The average number of shares traded per day over the past five days has been 3,617,340 shares. 2 times new highs have been achieved over the past 5 days, with a $3.51 gain in that time frame. In the last twenty days, the average volume was 1,905,285, while in the previous 50 days, it was 1,326,532.

Since last month, TNDM stock retreated -4.57%. Shares of the company fell to $35.27 on 02/28/23, the lowest level in the past month. A 52-week high of $123.96 was reached on 01/05/23 after having rallying from a 52-week low of $33.51. Since the beginning of this year, TNDM’s stock price has dropped by -8.48% or -$3.81, and marked a new high 3 times. However, the stock has declined by -66.81% since its 52-week high.

Do You Know The Best Place To Find Gains In Volatile Markets?

In today's chaotic marketplace, the biggest gains will come from some currently-small companies that pass by older, larger businesses still stuck in a pre-pandemic world. The trick is figuring out which small caps will be tomorrow's winners. That's why StockWire News has put together a special Wealth Building Report, highlighting 3 small cap stocks set to soar in 2023.

Click here for full details and to join for free.


TNDM stock investors should be aware that Tandem Diabetes Care Inc. (TNDM) stock had its last reported insider trading activity 15 days ago on Mar 03. BERGER DAVID B, the EVP & Chief Operating Officer of the company, disposed of 10,000 shares for $41.19 on Mar 03. It resulted in a $411,884 divestment by the insider. BERGER DAVID B sold 10,000 shares at an average price of $40.25 on Dec 16. The insider now owns 3,029 shares following the transaction. On Dec 15, EVP & Chief Operating Officer BERGER DAVID B sold 15,000 shares at $40.32 apiece. The transaction was valued at $604,800.

Valuation Metrics

The stock’s beta is 0.94. Besides these, the trailing price-to-sales (P/S) ratio of 3.47, the price-to-book (PB) ratio of 6.02, and the price-to-cash flow ratio of 169.53 may also be considered.

Financial Health

In the three months ended September 29, Tandem Diabetes Care Inc.’s quick ratio stood at 4.50, while its current ratio was 5.10, showing that the company is able to pay off its debt. According to company report, the long-term debt-to-equity ratio for the quarter ending September 29 was 0.64, and the total debt-to-equity ratio was 0.64. On the profitability front, the trailing twelve-month gross margin is 51.50% percent. In the year ended September 29, operating margins totaled -11.60%. Based on annual data, TNDM earned $412.99 million in gross profit and brought in $801.22 million in revenue.

A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was -13.10%. Return on equity (ROE) for the past 12 months was -21.60%.

According to the earnings report, the company had a higher net income in the recent quarter than it did in the previous quarter. TNDM’s revenue rose 4.76% to $204.55 million during the quarter, while net income inched up to $220.5 million. While analysts expected Tandem Diabetes Care Inc. to report -$0.05 quarterly earnings, the actual figure was -$0.76 per share. The liabilities of Tandem Diabetes Care Inc. were 612.84 million at the end of its most recent quarter ended September 29, and its total debt was $422.02 million.

Technical Picture

This quick technical analysis looks at Tandem Diabetes Care Inc.’s (TNDM) price momentum. With a historical volatility rate of 58.40%, the RSI 9-day stood at 52.82% on 17 March.

With respect to its five-day moving average, the current Tandem Diabetes Care Inc. price is up by +9.33% percent or $3.51. At present, TNDM shares trade -5.27% below its 20-day simple moving average and -24.14% percent below its 100-day simple moving average. However, the stock is currently trading approximately -11.53% below its SMA50 and -39.65% below its SMA200.

Stochastic coefficient K was 65.73% and Stochastic coefficient D was 67.21%, while ATR was 2.34. Given the Stochastic reading of 61.27% for the 14-day period, the RSI (14) reading has been calculated as 51.52%. As of today, the MACD Oscillator reading stands at 0.79, while the 14-day reading stands at 1.34.


Please enter your comment!
Please enter your name here